MYH11 mutations result in a distinct vascular pathology driven by insulin-like growth factor 1 and angiotensin IIH. Pannu, Dianna M. Milewicz, Van Tran‐Fadulu et al.|Human Molecular Genetics|2007Cited by 289
Overview of AKR1C3: Inhibitor Achievements and Disease InsightsYang Liu, Haopeng Sun, Feng Feng et al.|Journal of Medicinal Chemistry|2020Cited by 92
IP3R1 regulates Ca2+ transport and pyroptosis through the NLRP3/Caspase-1 pathway in myocardial ischemia/reperfusion injuryGuixi Mo, Yijun Liu|Cell Death Discovery|2021Cited by 81